Brendan Gilmore

Dr. Brendan Gilmore

School of Pharmacy, Queen's University Belfast, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2017 in Chemical Reviews
Verified
Journal Article
Closed access
SKStephen A. Kelly
Stephen A. Kelly
SPStefan Pohle
Stefan Pohle
SWScott Wharry
Scott Wharry
SMStefan Mix
Stefan Mix
CAChristopher C.R. Allen
Christopher C.R. Allen
Brendan GilmoreBrendan Gilmore
Brendan Gilmore

18 February 2009 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
LCLouise Carson
Louise Carson
PCPeter K. W. Chau
Peter K. W. Chau
MEMartyn J. Earle
Martyn J. Earle
MGManuela A. Gilea
Manuela A. Gilea
Brendan GilmoreBrendan Gilmore
Brendan Gilmore
KSKenneth R. Seddon
Kenneth R. Seddon
Microbial biofilms are ubiquitous in nature and represent the predominant mode of growth of microorganisms. A general characteristic of biofilm communities is that they tend to exhibit significant tolerance to antimicrobial challenge compared with planktonic bacteria of the same species The antibiofilm activity of a series of 1-alkyl-3-methylimidazolium chloride ionic liquids has been evaluated against a panel of clinically significant microbial pathogens, including MRSA. A comparison of antimicrobial activity against planktonic bacteria and established biofilms is presented. In general, these ionic liquids possess potent, broad spectrum antibiofilm activity.

1 July 2012 in FEMS Immunology & Medical Microbiology
Verified
Journal Article
Open access
PDF file
ERElizabeth M. Ryan
Elizabeth M. Ryan
MAMahmoud Y. Alkawareek
Mahmoud Y. Alkawareek
Ryan DonnellyRyan Donnelly
Ryan Donnelly
Brendan GilmoreBrendan Gilmore
Brendan Gilmore
The potential application of phage therapy for the control of bacterial biofilms has received increasing attention as resistance to conventional anti

1 October 2011 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
ERElizabeth M. Ryan
Elizabeth M. Ryan
SGSean P. Gorman
Sean P. Gorman
Ryan DonnellyRyan Donnelly
Ryan Donnelly
Brendan GilmoreBrendan Gilmore
Brendan Gilmore

31 August 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MAMahmoud Y. Alkawareek
Mahmoud Y. Alkawareek
QAQais Th. Algwari
Qais Th. Algwari
GLGarry Laverty
Garry Laverty
SGSean P. Gorman
Sean P. Gorman
WGWilliam G. Graham
William G. Graham
Brendan GilmoreBrendan Gilmore
Brendan Gilmore
Bacteria exist, in most environments, as complex, organised communities of sessile cells embedded within a matrix of self-produced, hydrated extracellular polymeric substances known as biofilms. Bacterial biofilms represent a ubiquitous and predominant cause of both chronic infections and infections associated with the use of indwelling medical devices such as catheters and prostheses. Such infections typically exhibit significantly enhanced tolerance to antimicrobial, biocidal and immunological challenge. This renders them difficult, sometimes impossible, to treat using conventional chemotherapeutic agents. Effective alternative approaches for prevention and eradication of biofilm associated chronic and device-associated infections are therefore urgently required. Atmospheric pressure non-thermal plasmas are gaining increasing attention as a potential approach for the eradication and control of bacterial infection and contamination. To date, however, the majority of studies have been conducted with reference to planktonic bacteria and rather less attention has been directed towards bacteria in the biofilm mode of growth. In this study, the activity of a kilohertz-driven atmospheric pressure non-thermal plasma jet, operated in a helium oxygen mixture, against Pseudomonas aeruginosa in vitro biofilms was evaluated. Pseudomonas aeruginosa biofilms exhibit marked susceptibility to exposure of the plasma jet effluent, following even relatively short (∼10′s s) exposure times. Manipulation of plasma operating conditions, for example, plasma operating frequency, had a significant effect on the bacterial inactivation rate. Survival curves exhibit a rapid decline in the number of surviving cells in the first 60 seconds followed by slower rate of cell number reduction. Excellent anti-biofilm activity of the plasma jet was also demonstrated by both confocal scanning laser microscopy and metabolism of the tetrazolium salt, XTT, a measure of bactericidal activity.

1 August 2015 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
JPJack Norman Pendleton
Jack Norman Pendleton
Brendan GilmoreBrendan Gilmore
Brendan Gilmore